1.Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance.
Yonghua, WANG ; Qianyuan, ZHUANG ; Siwei, ZHOU ; Zhiquan, HU ; Ruzhu, LAN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2009;29(1):77-9
B7-H1, a recently described member of the B7 family of costimulatory molecules, is thought to be involved in tumor immune escape by inducing T-cell apoptosis. In order to investigate the relationship between B7-H1 and immune escape of bladder cancer, B7-H1 expression in 50 cases of bladder cancer was detected by using immunohistochemical method. Survival curves were constructed using the Kaplan-Meier method and independent prognostic factors were evaluated using the Cox regression model. Our results showed that the positive rate of B7-H1 immunostaining in normal bladder tissue and bladder cancer was 0 and 72% respectively. The expression of B7-H1 was strongly associated with the pathological grade, clinical stage and recurrence (P<0.05). The survival rate was significantly lower in patients with B7-H1 positive group than in those with B7-H1 negative group and multi-variable analysis revealed that B7-H1 could be regarded as an independent factor in evaluating the prognosis of bladder cancer. It is concluded that the expression of B7-H1 is strongly associated with neoplastic progression and prognosis of bladder cancer. The manipulation of B7-H1 may become a beneficial target for immunotherapy in human bladder cancer.
Antigens, CD/genetics
;
Antigens, CD/*metabolism
;
Antigens, CD80/genetics
;
Antigens, CD80/*metabolism
;
Prognosis
;
Tumor Escape/*genetics
;
Urinary Bladder Neoplasms/*immunology
;
Urinary Bladder Neoplasms/metabolism
2.Suppression of Tumor Formation and Induction of Natural Killer Cell Activity in BALB/c Nude Mice by Human B7-1 (CD80) Gene Transfer Subcutaneously Injected with Human Hepatocellular Carcinoma Cells (Huh-7).
Seung Kew YOON ; Tai Gyu KIM ; Hyun Il CHO ; Bong Soo LEE ; Se Hyun CHO ; Nam Ik HAN ; Young Sok LEE ; Jeong Won JANG ; Kyu Won CHUNG ; Hee Sik SUN ; Boo Sung KIM
The Korean Journal of Hepatology 2003;9(2):124-134
BACKGROUND/AIMS: Immunogene therapy is extensively studied for a therapeutic modality of various cancers. This study was conducted to investigate the efficacy of immunogene therapy using the T-cell costimulatory molecule and human B7-1 (CD80, hB7-1) in an in vivo human hepatocellular carcinoma (HCC) model. METHODS: The stable HCC cell line expressing hB7-1 gene was established using retroviral vector (Huh-7/hB7-1). Of fourteen BALB/c nude mice, 7 were subcutaneously injected with 2 X 10(6) Huh-7/hB7-1 cells, while the other 7 were injected with 2 X 10(6) Huh-7/mock cells as a control group. After the injection, the mice were observed weekly for three months for subcutaneous tumor formation. Assay for natural killer (NK) cell cytotoxicity and serum IFN-gamma was performed at 1 and 2 weeks after inoculation. RESULTS: In BALB/c nude mice inoculated with Huh-7/hB7-1 cells, no tumor growth was observed. BALB/c nude mice inoculated with Huh-7/hB7-1 cells showed significantly increased NK cell activities of splenocytes compared with those with Huh-7/mock cells. Serum IFN-gamma was not measurable at 1 week, but significantly increased at 2 weeks after inoculation to the level of 470 pg/ml in BALB/c nude mice with Huh-7/mock cells and 521 pg/ml in BALB/c nude mice with Huh-7/hB7-1. CONCLUSIONS: Our results demonstrate the in vivo anti-tumor immunity and NK cell activation by transfer of hB7-1 gene into human HCC in xenogeneic BALB/c nude mice model. This approach may provide a tool for the development of immunogene therapies against human malignant tumors.
Animals
;
Antigens, CD80/*genetics
;
Cytotoxicity, Immunologic
;
Gene Transfer Techniques
;
Humans
;
Interferon-gamma/metabolism
;
Killer Cells, Natural/*immunology
;
Liver Neoplasms, Experimental/genetics/*immunology
;
Mice
;
Mice, Inbred BALB C
;
Mice, Nude
;
Neoplasm Transplantation
3.Impaired responses of leukemic dendritic cells derived from a human myeloid cell line to LPS stimulation.
Kwang Dong KIM ; Seung Chul CHOI ; Young Woock NOH ; Jong Wan KIM ; Sang Gi PAIK ; Young YANG ; Keun Il KIM ; Jong Seok LIM
Experimental & Molecular Medicine 2006;38(1):72-84
Several myeloid leukemia-derived cells have been reported to possess the ability to differentiate into dendritic cells (DC). MUTZ-3, a myeloid leukemia cell line, responds to GM-CSF, IL-4 and TNF-alpha, and acquires a phenotype similar to immature monocyte-derived DC (MoDC). In the present study, MUTZ-3-derived DC (MuDC) showed high level expression of HLA class II molecules, CD80 and CD86, and were able to function as potent antigen presenting cells as previously reported. Interestingly, MuDC maturation was induced by CD40-mediated stimulation, but not by LPS stimulation. We analyzed CCR1, CCR7 and Toll-like receptor (TLR) expressions in MuDC, and measured IL-10 and IL-12 production after maturation stimuli. Although MuDC expressed the mRNA for TLR4, a major component of the LPS receptor system, they did not show an enhanced level of CCR7 or cytokine production after LPS stimulation. In contrast, they responded to CD40 stimulation, which resulted in increased levels of CD83, CD86 and CCR7. Moreover, while LPSstimulated MoDC could potently stimulate NK cells in a DC-NK cell co-culture, LPS-stimulated MuDC failed to stimulate primary NK cells. Taken together, our findings suggest that, although MuDC express TLR4, unlike TNF-alpha and IL-1beta, LPS does not stimulate MuDC to acquire mature phenotypes, and they may have impaired activity to initiate innate immune response.
Antigens, CD40/metabolism/pharmacology
;
Antigens, CD80/metabolism
;
Antigens, CD86/metabolism
;
Blotting, Western
;
CD40 Ligand/metabolism/pharmacology
;
Cell Differentiation
;
Cell Line, Tumor
;
Coculture Techniques
;
Dendritic Cells/*drug effects/metabolism
;
Enzyme-Linked Immunosorbent Assay
;
Fluorescein-5-isothiocyanate
;
Fluorescent Antibody Technique, Indirect
;
Fluorescent Dyes
;
Humans
;
Interleukin-10/analysis/biosynthesis
;
Interleukin-12/analysis/biosynthesis
;
Killer Cells, Natural/metabolism
;
Leukemia, Myeloid/*pathology
;
Lipopolysaccharides/*pharmacology
;
Mitogen-Activated Protein Kinase 3/metabolism
;
RNA, Messenger/metabolism
;
Research Support, Non-U.S. Gov't
;
Reverse Transcriptase Polymerase Chain Reaction
;
Toll-Like Receptor 4/metabolism
;
Tumor Necrosis Factor-alpha/pharmacology
;
p38 Mitogen-Activated Protein Kinases/metabolism